Evidence map›Paper›PMID 38026242›Full record

ArticleJournal of inflammation research2023

Myeloid/Lymphoid Neoplasms with

Yang Gou, Yongjie Tang, Shuiqing Liu, Siyu Cheng, Xiaojuan Deng, Qin Wen, Yimei Feng, Xiangui Peng, Ping Wang, Xi Zhang

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of inflammation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Resistance to imatinib in aFrontiers in oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yang Gou *Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, People's Republic of China.
Yongjie Tang *Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, People's Republic of China.
Shuiqing LiuMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, People's Republic of China.
Siyu ChengMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, People's Republic of China.
Xiaojuan DengMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, People's Republic of China.
Qin WenMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, People's Republic of China.
Yimei FengMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, People's Republic of China.
Xiangui PengMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, People's Republic of China.
Ping WangMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, People's Republic of China.
Xi ZhangMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, People's Republic of China.
Xinqiao Hospital · CNArmy Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

ETV6fusionimatinibmyeloid/lymphoid neoplasmsPDGFRB

Identifiers

PMID38026242
PMCPMC10649033
OpenAlexW4388566378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.